Cargando…
Membrane proteomic analysis of pancreatic cancer cells
BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify po...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949717/ https://www.ncbi.nlm.nih.gov/pubmed/20831833 http://dx.doi.org/10.1186/1423-0127-17-74 |
_version_ | 1782187562570350592 |
---|---|
author | Liu, Xiaojun Zhang, Min Go, Vay Liang W Hu, Shen |
author_facet | Liu, Xiaojun Zhang, Min Go, Vay Liang W Hu, Shen |
author_sort | Liu, Xiaojun |
collection | PubMed |
description | BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify potential target proteins related to metastasis of pancreatic cancer. METHODS: Membrane/membrane-associated proteins were isolated from AsPC-1 and BxPC-3 cells and identified with a proteomic approach based on SDS-PAGE, in-gel tryptic digestion and liquid chromatography with tandem mass spectrometry (LC-MS/MS). X! Tandem was used for database searching against the SwissProt human protein database. RESULTS: We identified 221 & 208 proteins from AsPC-1 and BxPC-3 cells, respectively, most of which are membrane or membrane-associated proteins. A hundred and nine proteins were found in both cell lines while the others were present in either AsPC-1 or BxPC-3 cells. Differentially expressed proteins between two cell lines include modulators of cell adhesion, cell motility or tumor invasion as well as metabolic enzymes involved in glycolysis, tricarboxylic acid cycle, or nucleotide/lipid metabolism. CONCLUSION: Membrane proteomes of AsPC-1 (metastatic) and BxPC-3 (primary) cells are remarkably different. The differentially expressed membrane proteins may serve as potential targets for diagnostic and therapeutic interventions. |
format | Text |
id | pubmed-2949717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29497172010-10-06 Membrane proteomic analysis of pancreatic cancer cells Liu, Xiaojun Zhang, Min Go, Vay Liang W Hu, Shen J Biomed Sci Research BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors due to its high potential of local invasion and metastasis. The aim of this study was to characterize the membrane proteomes of pancreatic ductal adenocarcinoma (PDAC) cells of primary and metastatic origins, and to identify potential target proteins related to metastasis of pancreatic cancer. METHODS: Membrane/membrane-associated proteins were isolated from AsPC-1 and BxPC-3 cells and identified with a proteomic approach based on SDS-PAGE, in-gel tryptic digestion and liquid chromatography with tandem mass spectrometry (LC-MS/MS). X! Tandem was used for database searching against the SwissProt human protein database. RESULTS: We identified 221 & 208 proteins from AsPC-1 and BxPC-3 cells, respectively, most of which are membrane or membrane-associated proteins. A hundred and nine proteins were found in both cell lines while the others were present in either AsPC-1 or BxPC-3 cells. Differentially expressed proteins between two cell lines include modulators of cell adhesion, cell motility or tumor invasion as well as metabolic enzymes involved in glycolysis, tricarboxylic acid cycle, or nucleotide/lipid metabolism. CONCLUSION: Membrane proteomes of AsPC-1 (metastatic) and BxPC-3 (primary) cells are remarkably different. The differentially expressed membrane proteins may serve as potential targets for diagnostic and therapeutic interventions. BioMed Central 2010-09-13 /pmc/articles/PMC2949717/ /pubmed/20831833 http://dx.doi.org/10.1186/1423-0127-17-74 Text en Copyright ©2010 Liu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Liu, Xiaojun Zhang, Min Go, Vay Liang W Hu, Shen Membrane proteomic analysis of pancreatic cancer cells |
title | Membrane proteomic analysis of pancreatic cancer cells |
title_full | Membrane proteomic analysis of pancreatic cancer cells |
title_fullStr | Membrane proteomic analysis of pancreatic cancer cells |
title_full_unstemmed | Membrane proteomic analysis of pancreatic cancer cells |
title_short | Membrane proteomic analysis of pancreatic cancer cells |
title_sort | membrane proteomic analysis of pancreatic cancer cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949717/ https://www.ncbi.nlm.nih.gov/pubmed/20831833 http://dx.doi.org/10.1186/1423-0127-17-74 |
work_keys_str_mv | AT liuxiaojun membraneproteomicanalysisofpancreaticcancercells AT zhangmin membraneproteomicanalysisofpancreaticcancercells AT govayliangw membraneproteomicanalysisofpancreaticcancercells AT hushen membraneproteomicanalysisofpancreaticcancercells |